P21 is an ambiguous label. In neurotrophic-peptide literature it has been used for a ciliary-neurotrophic-factor-derived research compound also written P021; in cell-cycle biology, p21 usually means the CDKN1A protein. The exact sequence and terminal chemistry must be established before either literature set is applied.
What Are the Key P21 Research Specifications?
| Specification | Research record |
|---|---|
| Compound | P21 |
| Category | misc |
| Listed purity | >99% |
| Molecular weight | Depends on the complete modified P021 structure |
| Intended use | Laboratory research only |
Which P21 identity is relevant here?
The neurotrophic programme began with a CNTF-derived 11-mer, then produced shorter analogues. The compound reported as P21/P021 is based on the DGGLA motif and includes N-terminal acetylation, C-terminal amidation and an adamantane-related modification used to improve stability and exposure. Publications use typography that can obscure the modified residue, so a generic “synthetic peptide, ~1.5 kDa” description is not sufficient.
This compound is not the 21 kDa cyclin-dependent-kinase inhibitor p21Cip1 and should never be described simply as “p21” in methods or sample labels.
What mechanism has been proposed?
Mouse studies reported effects on dentate-gyrus neurogenesis, synaptic markers and memory-associated endpoints. Later work proposed altered LIF/CNTF signalling, increased BDNF-related signalling and downstream inhibition of GSK3β. These are preclinical pathway hypotheses; they do not establish a single direct receptor target for the modified peptide.
How should a P21 experiment be designed?
Write the complete chemical structure in the protocol. Compare the modified compound with the unmodified parent sequence and an adamantane-containing control. Use multiple neurogenesis markers and distinguish cell proliferation from neuronal maturation. If BDNF–TrkB or LIF signalling is claimed, measure proximal pathway changes and test dependency with receptor blockade or genetic perturbation.
How Should P21 Be Handled and Verified?
Require sequence, position and identity of the adamantane-related modification, terminal groups, counterion and intact mass. The hydrophobic modification can change solubility and nonspecific binding, so document vehicle composition, inspect for precipitation and quantify recovery in the assay matrix. Use low-binding tubes and single-use aliquots. HPLC area purity cannot resolve an incorrectly placed modification without identity data.
Which Sources Support P21 Research?
- Li et al., design of neurotrophic adamantane-containing peptides and P21, FEBS Letters (2010), DOI: 10.1016/j.febslet.2010.06.025.
- Kazim et al., long-term P021 study in a 3xTg-AD mouse model, Molecular Neurodegeneration (2017), PMID 28655344.
How Can P21 Results Be Interpreted Without Overclaiming?
The strongest P21 evidence connects identity to mechanism to phenotype in that order. For P21, chemical identity, target engagement and downstream phenotype are separate layers. A change in migration, viability or gene expression does not by itself prove the proposed molecular target. A useful study includes an orthogonal analytical identity check, a target-dependent perturbation and a second assay that measures the same biology by a different method. This design makes a positive result easier to reproduce and a negative result easier to interpret.
For citation-ready P21 reporting, provide raw concentration units, biological replicate counts, prespecified exclusions and the exact time point. Separate exploratory endpoints from confirmatory ones. If exposure was not measured, describe potency as nominal rather than intracellular or free concentration. Limit the conclusion to the model used; avoid converting a pathway observation into a claim about clinical benefit.
Is P21 for Research Use Only?
P21 is supplied for laboratory research only. It is not for human or veterinary use.
Browse Miscellaneous Research Peptides
What Are Common Questions About P21?
What is P21?
P21 is an ambiguous label. In neurotrophic-peptide literature it has been used for a ciliary-neurotrophic-factor-derived research compound also written P021; in cell-cycle biology, p21 usually means the CDKN1A protein. The exact sequence and terminal chemistry must be established before either literature set is applied.
How should researchers verify P21?
Confirm the exact molecular form on the lot certificate and pair chromatographic purity with an orthogonal identity method such as mass spectrometry or NMR. Use the molecular weight, counterion and content stated for that verified form when calculating molarity.
Is P21 intended for human use?
P21 is listed for controlled laboratory research only. It is not intended for human or veterinary use.